Sonic Incytes Medical Corp.
Creators of VELACUR: point-of-care AI guided ultrasound elastography for chronic liver diseases such as MASLD and MASH
Canada
41 employees
Series A
Total: $11.80M
Health Care, Medical Devices
General Information
Get notified when Sonic Incytes Medical Corp. moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Sonic Incytes Medical Corp.
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Canada Market
Health Care
About Sonic Incytes Medical Corp.
Taxonomy: Point-of-Care Diagnostics, AI Guided Imaging, Ultrasound Elastography, Chronic Liver Diseases, Diagnostic Solutions, Quantitative Ultrasound, Procedure Guidance, Medical Imaging, Fatty Liver Disease, Diagnostic Accuracy
Funding Rounds & Investors (5)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series A | •••••• | 8 |
|
07 Dec 2021 |
| Seed Round | •••••• | 2 |
|
28 May 2020 |
| Non Equity Assistance | •••••• | - | 12 Jun 2019 | |
| Seed Round | •••••• | - | 01 Sep 2018 | |
| Pre Seed Round | •••••• | - | 26 Oct 2016 |
Sonic Incytes Medical Corp. Alternatives & Competitors
Empowering Precision Healthcare with Innovative Portable Ultrasound Solutions
-logo.jpg "ENDRA Life Sciences (Nasdaq: NDRA)"){kind=logo}
Focused on early detection of liver disease
Innovations in Ultrasound.
FAQ About Sonic Incytes Medical Corp.
Don't just browse. Track.
Signal Tracker monitors Sonic Incytes Medical Corp. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.